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Abstract 
Dystroglycan is part of a large complex of proteins, the dystrophin-glycoprotein complex, which has been 
implicated in the pathogenesis of muscular dystrophies for a long time.  Besides muscular degeneration many 
patients manifest symptoms of neurological and cognitive dysfunction. Recent findings suggest that dystroglycan 
is implicated in brain development, synapse formation and plasticity, nerve-glia interactions and maintenance of 
the blood-brain barrier. 
Most research so far has focused on the functions of dystroglycan in muscle and neuromuscular junctions, while 
its role in the brain and interneuronal synapses has been neglected.  
This review will give an overview of the biochemistry of dystroglycan, its interaction with other proteins as well 
as its confirmed and hypothetical functions in the nervous system.  
 
 
Introduction 
In 1987 a laminin-binding membrane protein was found in brain tissue and was termed cranin (Smalheiser and 
Schwartz, 1987). Eight years passed until this protein proofed to be identical with dystroglycan, which was 
previously only thought to be associated with muscle membranes (Smalheiser and Kim, 1995). 
Dystroglycan gives mechanical stability to muscle fibres by linking the extracellular matrix on the extracellular 
surface with the actin cytoskeleton on the intracellular side. Furthermore, it is implicated in the formation of 
neuromuscular junctions. The function of dystroglycan and its associated proteins is impaired in a large group of 
hereditary diseases, the muscular dystrophies. Muscular dystrophies are among the most prevalent hereditary 
diseases and affect not only muscle, but do also cause neurological and cognitive symptoms. Recent findings 
revealed the presence of dystroglycan in many structures of the adult brain and peripheral nervous system which 
hint that it plays a broader role in neuronal functioning than has been expected. 
Structure and Biochemistry 
The dystroglycan gene (DAG1) encodes a single propeptide which is cleaved to yield two glycoproteins, α-
dystroglycan and β-dystroglycan (Holt et al., 2000). The roles of this cleavage and the protease or proteases 
involved are still unknown. Astonishingly, the two resultant proteins immediately associate again by a non-
covalent bond to form a tightly bound heterodimer. This complex is anchored in the cell membrane by the 
membrane-spanning β-dystroglycan and binds to extracellular partners via α-dystroglycan (Figure 1). This α - β 
– dimer is from now on simply referred to as ‘dystroglycan’, while the complex formed by dystroglycan together 
with its intracellular binding partners is referred to as ‘dystroglycan complex’. 
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Figure 1: The mature dystroglycan heterodimer. Dystroglycan is translated as a single propeptide that contains both α – and β – subunits. 
The propeptide is cleaved, but both subunits form non – covalent bonds and reassemble to a tightly bound heterodimer. β – dystroglycan 
anchors the complex in the cell membrane and binds to intracellular partners, while α – dystroglycan binds to the extracellular matrix and 
other binding partners. The heterodimer is subject to extensive glycosylation. Carbohydrates make up the half of the mass of mature 
dystroglycan. The mucin – like domain of α – dystroglycan and the PPxY motif of β – dystroglycan are marked. C: C – terminal, N: N – 
terminal. 
Glycosylation 
Glycosylation is quite extensive and about half of the molecular weight of α-dystroglycan is made up of 
oligosaccharides. The glycans are anchored on a mucin – like domain in the middle of α-dystroglycan. 
While only a single form of the dystroglycan protein is known there seems to be a wide scope for different forms 
of glycosylation. Depending on the extent of glycosylation, the molecular mass of dystroglycan can range from 
around 156 kDa in skeletal muscle to 140 kDa in cardiac muscle and 120 kDa in brain and peripheral nerve 
(Muntoni et al., 2004a). In the myotubes formed by the C2C12 cell line two different forms of dystroglycan were 
detected (McDearmon et al., 2001). This suggests that even single cells (or syncytia) are able to produce 
differently glycosylated forms of dystroglycan, possibly targeted to distinct structures on the cell surface. Most 
of the extracellular interactions of dystroglycan are dependent on glycosylation, and different glycoforms show 
distinct binding characteristics to endogenous ligands, lectins and antibodies (Ervasti et al., 1997). However, all 
of the known glycoforms in healthy organisms do bind to all of the known ligands of dystroglycan. Thus, the 
differences observed between glycoforms in vivo do not seem to change their biological function fundamentally. 
Degradation 
In peripheral nerve and other tissues, the cytosolic end of β-dystroglycan can be cleaved by matrix 
metalloproteinases (MMPs), leading to the formation of a 30 kDa dystroglycan fragment and the disintegration 
of the dystroglycan complex (Yamada et al., 2001b). The same study did not find this fragment in brain, but it is 
likely that other cleavage mechanisms are active there. 
Localisation 
Dystroglycan is distributed throughout the basement membranes of the whole body and was found in most 
tissues and organs examined in rodents (Durbeej et al., 1998), primates (Royuela et al., 2003) and teleost fish 
(Guyon et al., 2003). Homologues have also been identified in D. melanogaster (Dekkers et al., 2004) and C. 
elegans (Grisoni et al., 2002; Segalat, 2002). 
Zaccaria et al. employed an antibody against α – dystroglycan to map the distribution of dystroglycan in adult 
mouse brain (Zaccaria et al., 2001a) and found dystroglycan in neurons of the cerebral cortex, hippocampus, 
olfactory bulb, basal ganglia, thalamus, hypothalamus, brainstem and cerebellum, but not at other areas. 
Dystroglycan was also found on perivascular astrocytes and blood vessels. On neurons, dystroglycan was 
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preferentially located to somata and apical dendrites, filling the cytosol. Electron microscopical examination 
revealed that dystroglycan staining was primarily found on postsynaptic specialisations and endoplasmic 
reticulum. The antibody against dystroglycan was bound at somata and apical dendrites of pyramidal cells in 
cortex and CA1 – CA3 of the hippocampus. The subiculum and granule cells of the dentate gyrus were also 
weakly stained. In the olfactory bulb, staining was observed on a subset of both excitatory and inhibitory dendro 
- dendritic synapses between mitral and granule cells. In the brainstem the reticular formation, vestibular 
nucleus, raphe and olivary nuclei were stained. In the cerebellum, Purkinje cells were the only neurons stained 
strongly.  
The results of Zaccaria et al. match previous studies that detected dystroglycan on the mRNA – level (Gorecki et 
al., 1994) with one exception: dystroglycan mRNA has not been detected in the cortex, while dystroglycan 
protein has. This discrepancy might be due to a lower turnover of dystroglycan in these areas, accompanied by a 
lower mRNA level. 
In the superior cervical ganglion, a part of the sympathetic nervous system, dystroglycan was found on the 
postsynaptic apparatus of intraganglionic, cholinergic synapses (Zaccaria et al., 1998a). Dystroglycan reactivity 
was also seen on synapses formed by dissociated neurons of the superior cervical ganglion in vitro (Gingras and 
Ferns, 2001b). 
Dystroglycan and associated proteins have been found in the vitreal border and at ribbon synapses of the outer 
plexiform layer of the retina (Blank et al., 2002). Contrasting the findings on other synapses, dystroglycan is 
located to the presynaptic side of the synapses of the outer plexiform layer (Blank et al., 1997).  
Binding Partners and Interactions 
Dystroglycan has been found to interact with a multitude of proteins on both the extracellular and the 
intracellular side (Figure 2), confirming its versatile role in many cellular functions. Dystroglycan has no 
apparent ability to transduce signals from the extracellular to the intracellular side by itself, so any signals that 
involve the binding of dystroglycan are dependent on secondary mechanisms, like the clustering of proteins. In 
the following section all of the binding partners and their confirmed localizations inside the nervous system are 
reviewed. 
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Table 1: Direct and indirect binding partners of dystroglycan. Indirect binding is diagrammed by hierarchical indention (e.g. 
dystroglycan binds dystrophin, which binds dystrobrevin, which binds dysbindin). Abbreviations: Neur.: expression in 
neurons, Glia: expression in glia. A + sign marks evidence for presence, a – sign marks evidence for absence. 
Binding partner Main function Neur. Glia  References 
Extracellular / Transcellular 
Laminin Extracellular matrix + + (Colognato and Yurchenco, 2000c; Ido et 
al., 2004a; Indyk et al., 2003) 
Perlecan Extracellular matrix + + (Shee et al., 1998b) 
Agrin Extracellular matrix, 
transmembrane protein of 
neurons, messenger 
+ + (Smith and Hilgenberg, 2002d) - Review 
Biglycan Messenger, extracellular 
matrix 
 + (Bowe et al., 2000c) 
Neurexin Transmembrane protein of 
neurons, recruits 
presynaptic apparatus 
+  (Sugita et al., 2001a; Dean et al., 2003a) 
Intracellular 
Dystrophin Adaptor, binds actin + + (Knuesel et al., 2001a; Mehes et al., 
2003) 
   Dystrobrevin Adaptor + + (Blake et al., 1998) 
       nNOS Nitric oxide synthesis + +  
       Dysbindin unknown +  (Benson et al., 2001a) 
       DAMAGE Putative signalling 
molecule 
+ + (Albrecht and Froehner, 2004b) 
       Syncoilin  Desmin binding   (Newey et al., 2001a) 
       Desmuslin Desmin binding   (Mizuno et al., 2001) 
   Syntrophin Adaptor + + (Gorecki et al., 1997b; Guadagno and 
Moukhles, 2004a) 
       Calmodulin Calcium signalling + +  
       Sodium channels  + + (Gee et al., 1998a) 
       Kir4.1 potassium channel Inward rectifier  + (Connors et al., 2004b) 
       Grb2 Adaptor + +  
       ErbB4  Neuregulin receptor + + (Garcia et al., 2000) 
       SAPK3 Kinase   (Hasegawa et al., 1999) 
       MAST, SAST Putative binding of 
microtubules, kinases  
+ + (Yano et al., 2003; Lumeng et al., 1999a) 
      TAPP Phosphatidylinositol 3,4-
bisphosphate binding 
  (Hogan et al., 2004) 
Utrophin  Adaptor (binding profile 
resembles dystrophin) 
+ + (Knuesel et al., 2002a; Mehes et al., 
2003) 
Actin  + +  
Ezrin Connects dystroglycan to 
actin in glia cells 
 + (Spence et al., 2004a) 
Grb2 Adaptor + +  
   FAK (focal adhesion kinase) Integrin binding, 
signalling, neuronal 
migration, cell cycle, cell 
survival, putative role in 
synaptic plasticity 
+ + (Burgaya et al., 1995a; Parsons, 2003) - 
Reviews 
Caveolin-3 Formation of caveolae - + (Ikezu et al., 1998b) 
Rapsyn Acetylcholine receptor 
clustering 
+  (Burns et al., 1997c) 
   Nicotinic ACh receptors  +   
ERK, MEK2 Kinases + + (Spence et al., 2004c) 
Dynamin 1 Endocytosis +  (Zhan et al., 2005a) 
Transmembrane 
Sarcoglycan Unclear, might stabilize 
dystroglycan 
+ + (Nishiyama et al., 2004a; Xiao and 
LeDoux, 2003b) 
Sarcospan Unknown - - (Crosbie et al., 1997a; Imamura et al., 
2000c) 
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Figure 2: Possible molecular interactions of dystroglycan in neurons and glia. Not all known interactions are depicted, see table 1 for 
comparison. The domain structures of agrin and laminin are delineated. Laminin, perlecan, agrin, neurexin and biglycan bind to extracellular 
α dystroglycan. The binding of biglycan does not depend on the glycosylation of dystroglycan, while binding of other extracellular partners 
does. The binding of agrin and laminin and probably also perlecan is competitive. The SN variant of agrin is bound to cell membranes, while 
the LN variant is secreted and has an additional laminin – binding domain. A small ‘z’ marks the z – splice site of agrin. The β - neurexins 
have one binding site for dystroglycan while α neurexins have two. Neurexins are connected to intracellular scaffolding complexes via 
CASK. The intracellular portion of dystroglycan contacts the cytoskeleton, ion channels and other proteins through adaptor proteins. 
Caveolin -3 and Grb2 compete with Dystrophin for the binding site near the C – terminal of dystroglycan. GABA(A) – receptors colocalize 
with dystroglycan in some neurons, but there has been no proof of a direct interaction.  Abbreviations: α: alpha subunit of dystroglycan, β: 
beta subunit of dystroglycan, ε SG: sarcoglycan epsilon, SN / LN agrin: short N-terminal variant / long N-terminal variant of agrin. 
GABA(A): GABA(A) receptors, nAChR: nicotinic acetylcholine receptors, z: z splice site of agrin. See text for references. Agrin domain 
structure was adapted from (Smith and Hilgenberg, 2002c), dystroglycan domain structure was adapted from (Winder, 2001), neurexin 
domain structure was adapted from (Sugita et al., 2001c). 
Extracellular / Transcellular 
Five extracellular or transcellular binding partners for dystroglycan could be identified up to now. The three 
heparan sulphate proteoglycans laminin, agrin and perlecan are abundant components of the extracellular matrix 
of many tissues. The small proteoglycan biglycan is a messenger molecule the roles of which are still not known 
in its entirety. The transmembrane proteins of the neurexin family are found on neurons and have drawn 
attention as important mediators of presynaptic differentiation. The binding of biglycan is not dependent on 
glycosylation of dystroglycan (Bowe et al., 2000b), while the binding of the other ligands can be attenuated or 
totally abolished by a lack of glycosylation. 
Laminin 
Laminins are large heterotrimeric glycoproteins and are a major component of the extracellular matrix. The 
three subunits (α, β, γ) form a large aggregate in the shape of a cross. To date, five α, three β and three γ subunits 
have been identified. Laminin 1 (α1β1γ1), laminin 2 (‘merosin’,  α2β1γ1), laminin 3 (α1β2γ1), laminin 4 
(α2β2γ1) and laminin 10 (α5β1γ1) are known to bind to dystroglycan through their G domains (Colognato and 
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Yurchenco, 2000b; Ido et al., 2004b). Most laminins bind to integrins on the cell surface and to agrin and other 
laminin molecules in the extracellular matrix (Colognato and Yurchenco, 2000a). 
Localisation: The expression profile of laminin in the brain does not always seem to fit its classical roles in other 
tissues. The laminin γ3 subunit is expressed in many areas of the brain and seems not to be associated with 
basement membranes (Koch et al., 1999). One study found laminin α2 subunits on neurites and potentially 
synaptic structures (Hagg et al., 1997b). In adult hippocampus, α2 immunoreactivity is associated with dendritic 
spines (Patton et al., 1998b) and a disruption of long term synaptic plasticity can be observed in cerebellar slice 
cultures of α2 deficient mice (Anderson et al., 2005). The γ1 subunit was found on somata and proximal 
processes (Hagg et al., 1997a). A newer study found that all subunits are expressed in the whole hippocampus, 
and that α5, β1 and γ1 are expressed in hippocampal neurons, suggesting that laminin 10 (α5β1γ1) is the primary 
isoform in these neurons (Indyk et al., 2003). Laminins in the hippocampus are degraded via a plasmin-mediated 
mechanism after excitotoxic injury, which in turn triggers neuronal apoptosis. Dystroglycan binds to laminin 10 
(Ido et al., 2004c) and could be involved in these processes. 
Perlecan 
Perlecan binds a multitude of proteins of the extracellular matrix. It also binds to acetylcholinesterase at the 
neuromuscular junction. 
Localisation: Small amounts of perlecan can be found in the intact adult hippocampus. Contrasting the findings 
on laminin expression, perlecan expression is elevated in neurons and glia after excitotoxic injury (Shee et al., 
1998a). 
Agrin 
Agrin is encoded by a single gene, but the occurrence of alternative splicing at three sites and two alternate 
transcriptional start sites produces a wide array of gene products. Of the splice sites, the z site has the most 
prominent influence on the function of agrin: agrinz+ contains inserts at the z splice-site and causes clustering of 
acetylcholine receptors at the neuromuscular junction. Conversely, agrinz- does not contain inserts at this site and 
does not show clustering activity at the NMJ. The z- isoform is expressed by both neuronal and non-neuronal 
cells, while the z+ isoform is only expressed by neurons, and dystroglycan binds both of them. Furthermore, 
agrin isoforms with a long (LN) or a short (SN) N – terminus are produced, dependent on the transcriptional start 
site. The long isoforms bind laminin and are expressed in various cells and tissues, including muscle and 
motoneurons. The short isoforms lack a laminin binding site and are not secreted, but exist as transmembrane 
proteins specifically expressed by neurons. It was also suggested that agrin interacts with neurons through 
neuronal integrins, but it is left unclear whether this interaction is caused by laminins bound to the agrin or not 
(Burgess et al., 2002). Agrin and laminin compete for the same binding site on dystroglycan (Gee et al., 1994). 
For a good review of the known roles of agrin in the nervous system, see (Smith and Hilgenberg, 2002b). 
Biglycan 
Biglycan was found to be a binding partner of dystroglycan and is upregulated in dystrophic muscle (Bowe et 
al., 2000a). Besides dystroglycan, it has been found to bind collagen (Pogany et al., 1994), apolipoprotein E 
(Klezovitch and Scanu, 2001) and others. 
Biglycan was found to be upregulated during brain development (Kikuchi et al., 2000a) and at sites of 
mechanical brain injury for at least up to six months after the lesion (Stichel et al., 1995). It is expressed by glia 
cells, was shown to be neurotrophic (Junghans et al., 1995) and to stimulate growth of microglial cells in vitro 
(Kikuchi et al., 2000b). Intracerebral injection of biglycan into the nucleus basalis magnocellularis facilitated 
learning and activated the cholinergic system (Hasenohrl et al., 1995; Huston et al., 2000). 
 
Neurexin  
Neurexins are a family of cell-surface proteins exclusively found on neurons. Three genes encoding neurexins 
are known, each of the genes has two promoters that can give rise to either a long (α neurexin) or a short (β 
neurexin) transcript (Figure 2, top). Due to extensive alternative splicing more than thousand isoforms of 
neurexin are possible (Missler et al., 1998). They probably serve as signalling receptors and cell adhesion 
molecules. During synapse formation, the β neurexins on the presynaptic side are bound to neuroligin anchored 
on the postsynaptic side and initiate the formation of the presynaptic active zone. The α neurexins do not bind 
neuroligin but are receptors for messenger molecules termed neurexophilins.  
Sugita et al. found that dystroglycan is a binding partner of both α and β neurexins in rat brain (Sugita et al., 
2001b). β neurexins have one binding site for dystroglycan, while the larger α neurexins have two binding sites, 
giving them the potential ability to cluster dystroglycan. Dystroglycan is the only known membrane-bound 
ligand for the α-neurexins known so far, and the expression of dystroglycan and α-neurexins in postnatal brain 
development in rats shows some correlation. The function and ultrastructural localisation of this significant 
interaction are still unknown.   
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Intracellular 
The most important intracellular ligands of dystroglycan are dystrophin and utrophin, which act as adaptors 
between dystroglycan and other binding partners, including the actin cytoskeleton. Newer findings have added 
rapsyn, actin, ezrin, Grb2/FAK and caveolin-3 to the group of binding partners. 
Dystrophin 
The dystrophin gene is the largest gene described in the human genome. The gene contains 7 promotors that 
give rise to several tissue specific isoforms with a great variability in molecular weight. The first three promotors 
produce proteins with a molecular weight of 427 kDa and are associated with cortex/hippocampus, cerebellar 
Purkinje cells and muscle, respectively. The other promotors produce proteins with a lower molecular weight: 
260 kDa (primarily found in the retina), 140 kDa (brain, retina, kidney), 116 kDa (Schwann cells) and 71 kDa 
(most tissues including brain). The full-length isoforms (427 kDa) bind to actin with the N – terminal end; the 
shorter isoforms are unable to bind to actin. All isoforms seem to bind dystroglycan and the other members of 
the dystrophin-glycoprotein complex (DGC). 
Localisation: In brain, dystrophin was found at postsynaptic GABA(A) receptors of the cortex, hippocampus and 
cerebellum (Knuesel et al., 2001b). It is colocalized with dystroglycan in most if not all instances (Levi et al., 
2002a). 
Utrophin 
Utrophin is structurally and functionally closely related to dystrophin and can partially substitute for dystrophin 
when dystrophin function is disturbed (i.e. through mutations).  
The binding of utrophin and dystrophin is abolished when dystroglycan is phosphorylated on a tryrosine residue 
(James et al., 2000; Ilsley et al., 2001). This phosphorylation is triggered by cell adhesion, but the kinase 
involved is still unknown. 
Localisation: It is found in large sensory and motor brain stem neurons (Knuesel et al., 2002b). Different to 
dystrophin, utrophin is located extrasynaptically and seems to give support to neuronal membranes (Knuesel et 
al., 2001c). 
 
Dystrophin/utrophin bind other intracellular members of the DGC: dystrobrevin (which in turn binds neuronal 
nitric oxide synthase / nNOS, dysbindin (Benson et al., 2001b), syncoilin (Newey et al., 2001b) and DAMAGE 
(Albrecht and Froehner, 2004a)), and syntrophin (binds Calmodulin, Na+ channels (Gee et al., 1998b), the 
potassium channel Kir4.1 (Connors et al., 2004a), Grb2, ErbB4, MAST/SAST (Yano et al., 2003; Lumeng et al., 
1999b) and might also be responsible for the correct localisation of aquaporin-4 (Neely et al., 2001)).  
Localisation: Dystrobrevin has been found to be expressed in the developing and adult brain (Lien et al., 2004; 
Enigk and Maimone, 1999) and retina (Blank et al., 2002). Isoforms of syntrophin are found at all sites where 
dystrophin and utrophin are located, with the exception of Purkinje neurons (Gorecki et al., 1997a). 
Actin 
Actin was found to be able to directly bind to dystroglycan (Chen et al., 2003), through a mechanism not 
dependent on dystrophin or utrophin. Overexpression of dystroglycan in cultured cells caused aberrant bundling 
of actin filaments. 
  
Ezrin  
Ezrin binds to the juxtamembrane region of dystroglycan and the two proteins are colocalized in microvilli 
(Spence et al., 2004b). Ezrin interacts with actin, and disturbance of the dystroglycan-ezrin interaction reduced 
microvilli-like surface protrusions in cell culture. 
Localisation: Ezrin was found in glia cells, but not in neurons.  
Grb2 and FAK 
Growth factor receptor 2 (Grb2) is an adaptor protein involved in signal transduction. It binds dystroglycan with 
high affinity and competes with dystrophin for the binding site on dystroglycan (Russo et al., 2000). Via Grb2, 
dystroglycan can interact with the C – terminal domain of focal adhesion kinase (FAK) (Cavaldesi et al., 
1999b). As the name implies, FAK is most commonly, but not exclusively, associated with focal adhesions, and 
the N – terminal domain of FAK binds to intracellular portions of integrins. Thus, FAK might act as a direct 
functional connection between dystroglycan and the integrin system. The N – terminal domain of FAK shows 
sequence similarities with ezrin and other related proteins, but does not seem to be able to directly bind to 
dystroglycan (Cavaldesi et al., 1999a).  
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Autophosphorylation of FAK is important for its function, and the major isoform found in brain neurons 
(FAK+6,7) is marked by its stronger tendency towards autophosphorylation. Activation of FAK recruits kinases of 
the Src – family, which influence many important intracellular signalling cascades (Girault et al., 1999a). 
Up to now, the Dystroglycan/Grb2/FAK – interaction has not been investigated in vivo. 
Localisation: In the nervous system, FAK is ubiquitously expressed but tightly regulated during development. 
Highest levels in the brain are reached during late embryonic stages. In adult rats, FAK is especially 
concentrated in the cortex and hippocampus, particularly at neural cell bodies and large dendrites. Neurons in 
primary culture exhibit reactivity in growth cones and perikarya at early stages and a diffuse distribution at later 
stages. Cultured astrocytes show FAK reactivity associated with tight junctions (Burgaya et al., 1995b). For a 
review, see (Girault et al., 1999b). 
Caveolin-3 
Caveolin-3 can bind to the C – terminus of beta dystroglycan and competes with dystrophin for this binding site 
(Sotgia et al., 2000). Consistently, overexpression of caveolin-3 in skeletal muscle leads to a disruption of the 
dystroglycan – dystrophin interaction which is accompanied by muscular dystrophy (Galbiati et al., 2000). 
Caveolins are thought to act as scaffolding proteins in the formation of caveolae, 50 – 100 nm large 
invaginations found on the membranes of most cell types. 
Localisation: In muscle, caveolin-3 is preferentially localized to neuromuscular junctions, probably interacting 
with dystroglycan (Carlson et al., 2003). In brain, caveolins 1, 2 and 3 are expressed. Caveolin 3 was 
predominantly found on the endfeet of astrocytic processes, but not on neurons (Ikezu et al., 1998a). 
Dystroglycan is also present at astrocytic endfeet (Guadagno and Moukhles, 2004b). 
Rapsyn  
The cytoplasmic juxtamembrane region of dystroglycan binds rapsyn, a protein which is essential for the 
clustering and stabilisation of acetylcholine receptors at the neuromuscular junction, as well as the linkage of the 
utrophin complex to these clusters (Cartaud et al., 1998). Rapsyn was also found to cluster GABAA receptors in 
vitro (Yang et al., 1997). 
Localisation: Besides muscular endplates, rapsyn was found to be expressed in brain and cultured neurons of the 
parasympathetic ciliary ganglion (Burns et al., 1997b). 
ERK, MEK2 
The kinases MEK2 (mitogen-activated protein kinase kinase 2) and ERK (extracellular signal-regulated kinase) 
bind to dystroglycan and are colocalized with dystroglycan in cultured fibroblasts (Spence et al., 2004d). MEK2 
and ERK are part of an important signalling cascade, the receptor tyrosine kinase/Ras/Raf/MAP kinase pathway. 
These kinases are involved in a vast number of cellular processes, including synaptic plasticity. 
Dynamin 1 
Dynamin is a GTPase that is involved in endocytosis in all cell types including neurons, where it is involved in 
the recycling of presynaptic vesicles and receptor internalization. Zhan et al. report that dynamin 1 has an 
affinity for dystroglycan (Zhan et al., 2005b). They also showed that dynamin immunoreacticity is colocalized 
with dystroglycan reactivity in the presynaptic portions of synapses in the outer plexiform layer of the retina. 
Furthermore, they found that fibroblastic cells with a disruption of the dystroglycan showed increased 
endocytosis of transferrin compared to control. 
Transmembrane 
The sarcoglycans and sarcospan are transmembrane proteins associated with the dystroglycan complex. 
Sarcoglycan 
Sarcoglycans are important for the stability of dystroglycan. Six sarcoglycans (α, β, γ, δ, ε, ζ) are known, but 
only ε-sarcolgycan is expressed in brain.  
Localisation: ε -sarcoglycan is accumulated on neurons in the olfactory bulb, cortex, hippocampus, cerebellar 
cortex and substantia nigra and is colocalised with α2-laminin (Nishiyama et al., 2004b; Xiao and LeDoux, 
2003a). It is also expressed in astrocytes. The neuronal expression pattern overlaps with that of other 
components of the DGC. β, δ, and ε-sarcoglycans were found on the myelin sheath of peripheral nerve (Imamura 
et al., 2000b). 
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Sarcospan 
Sarcospan is a transmembrane protein that is associated with the DGC via Sarcoglycan. It seems to be absent 
from neurons and nervous tissue (Crosbie et al., 1997b; Imamura et al., 2000a). 
 
Human Diseases and Animal Models 
Total gene-knockout of dystroglycan is lethal in early embryonic stages in rodents. There are no known diseases 
that involve a mutation in the dystroglycan gene and no mutations have been described so far. However, there 
are several common hereditary diseases that are caused by aberrant glycosylation of dystroglycan, which leads to 
a loss of its main functions.  
 
Five distinct human diseases that affect the glycosylation of dystroglycan have been identified up to now: 
Fukuyama type congenital muscular dystrophy (Kobayashi et al., 1998a), MDC1C (Brockington et al., 2001a), 
MDC1D (Longman et al., 2003b), muscle-eye-brain disease (Yoshida et al., 2001a) and Walker-Warburg 
syndrome (Beltran-Valero et al., 2002b; Kim et al., 2004b). All of them are caused by a mutation in a 
glycosyltransferase. 
 
Table 2: Genetic diseases that are known to be caused by a hypoglycosylation of dystroglycan. 
Disease Gene Function References 
Fukuyama type 
congenital muscular 
dystrophy 
Fukutin Putative glycosyl-
transferase 
(Kobayashi et al., 1998b) 
MDC1C Fukutin-related 
protein 
Putative glycosyl-
transferase 
(Brockington et al., 2001b) 
MDC1D LARGE Putative glycosyl-
transferase 
(Longman et al., 2003a) 
Muscle-eye-brain 
disease 
POMGnT1 O-mannosyl glycan 
synthesis 
(Yoshida et al., 2001b) 
Walker-Warburg 
syndrome 
POMT1, POMT2 Putative O-mannosyl-
transferases 
(Beltran-Valero et al., 2002a; Kim et 
al., 2004a; van Reeuwijk et al., 2005) 
 
Defects in the glycosylation of dystroglycan have grave consequences on brain development, and these effects 
might well obscure other defects in the nervous system. All forms of hypoglycosylation of dystroglycan in the 
brain lead to failures of neuronal migration, anomalies in the retina, disruption of cortical layering and 
lissencephaly, to varying degrees (Muntoni et al., 2004b). Targeted deletion of dystroglycan in brain leads to 
similar symptoms (Moore et al., 2002b). The cause of these disorders lies mainly in the disruption of interactions 
between neurons and glia cells during early brain development. Accordingly, masking of dystroglycan by 
antibodies inhibited granule neuron migration in cerebellar slice cultures (Qu and Smith, 2004). In addition to 
the defects in brain development, some forms of myodystrophy cause neurofibrillary degeneration in the cortex 
(Oka et al., 1999). 
 
Interestingly, deficiency of FAK, a kinase that binds to the dystroglycan complex, can give rise to comparable 
abnormalities in brain development (Beggs et al., 2003). For a review of the roles of FAK in neuronal migration, 
see (Nikolic, 2004). 
 
The mydLARGE mouse is an established animal model for human myodystrophies (Grewal and Hewitt, 2002). 
These mice have a mutation in the gene encoding the glycosyltransferase LARGE, which parallels the mutation 
in the human disease MDC1D. Besides muscle pathology, mydLARGE mice exhibit eye and brain defects 
resembling those seen in human myodystrophies (Holzfeind et al., 2002). 
 
The aberrant glycosylation seen in human myodystrophies and in mydLARGE mice abolishes the interaction of 
dystroglycan with its main extracellular ligands: laminin, agrin and neurexin (Michele et al., 2002). It can be 
presumed that binding to perlecan is affected as well. It is likely that the loss of binding to these molecules is the 
main mechanism of the pathology of these diseases, although erroneous cellular targeting of incorrectly 
glycosylated dystroglycan might also play a role. A mutation in the dystrophin gene causes Duchenne muscular 
dystrophy, a disease with symptoms comparable to those caused by hypoglycosylation of dystroglycan. 
Infectious Diseases 
Alpha dystroglycan is the cellular receptor for lymphocytic choriomeningitis virus, lassa fever virus and 
mycobacterium leprae (Cao et al., 1998; Rambukkana et al., 1998). M. leprae, the causative agent of leprosy, 
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targets dystroglycan/α2-laminin – complexes on Schwann cells and leads to demyelinization and secondary 
nerve degeneration. 
Synaptic function 
There exists a large quantity of research on the role of dystroglycan in the function of neuromuscular synapses, 
opposed to a relatively small number of studies that deal with dystroglycan at interneuronal synapses. It can be 
assumed that there is at least some functionality of dystroglycan common to both types of synapses. It is 
therefore warranted to examine the current theories about dystroglycan in the neuromuscular junction and to 
subsequently check for possible parallels in interneuronal synapses. 
Function at the NMJ 
At the neuromuscular junction, dystroglycan in the postsynaptic membrane acts as a binding partner for 
molecules of the extracellular matrix and is involved in the formation of postsynaptic clusters of acetylcholine 
receptors in response to agrin and laminin. There exists a complex interplay between dystroglycan and the 
muscle specific kinase MuSK . MuSK does not bind agrin directly, but it is an important part of a signal cascade 
involved in the clustering of acetylcholine receptors induced by agrin. In vitro agrin alone is sufficient to trigger 
acetylcholine receptor clustering, the formation of a synapse-specific extracellular matrix and the recruitment of 
the subsynaptic apparatus (reviewed in (Patton, 2003)).  
Altough MuSK alone is sufficient to trigger clustering in vitro, muscular synaptogenesis is disturbed in chimeric 
mice lacking dystroglycan (Cote et al., 1999). Conversely, overexpression of dystroglycan in cultured myotubes 
interferes with agrin-induced acetylcholine receptor clustering (Heathcote et al., 2000), as does overexpression 
of its β-subunit (Kahl and Campanelli, 2003). The inhibitory activity is dependent on an intact juxtamembrane 
region, but not on those sites that bind extracellular and most intracellular ligands (like dystrophin/utrophin and 
probably rapsyn). These contradictive findings have not been integrated into one satisfying theory so far. 
Laminin is also able to induce clustering of acetylcholine receptor in vitro through a mechanism different to that 
of agrin (Lee et al., 2002). This action of laminin is dependent on dystroglycan (Jacobson et al., 2001). 
Expression of the laminin β2 – chain is crucial for the development of motoric endplates. Furthermore, the 
number of presynaptic active zones and junctional folds in β2 knockout mice is reduced and the exclusion of 
Schwann cells from the synaptic cleft is hampered. Generally, the active exclusion of glia cells by certain 
laminin isoforms might be crucial for synaptic stability at neuromuscular junctions (Patton et al., 1998a).  
Mice with a disrupted glycosylation of dystroglycan (mydLARGE) show disorganized muscular endplates, 
simplified presynaptic endings and a decreased binding of bungarotoxin to muscular acetylcholine receptors 
(Ruth Herbst and Reginald Bittner, unpublished observation). 
Dystroglycan seems to stabilize acetylcholine receptor clusters by forming a supportive intracellular scaffold, 
while MuSK is needed for the initiation of clustering. The role of dystroglycan seems to be the general binding 
of extraceullar matrix molecules, rather than binding to agrin specifically.  
 
It is important to be aware that neither MuSK nor a functional equivalent has been found at interneuronal 
synapses up to now. Moreover, molecules of the extracellular matrix are largely absent from the narrow 
interneuronal synaptic clefts. 
 
Rapsyn is essential for clustering of acetylcholine receptors at the neuromuscular junction triggered by activation 
of MuSK, and it associates with dystroglycan. Rapsyn – knockout mice do not form acetylcholine receptor 
clusters at neuromuscular junctions and die within hours after birth. Isoforms of rapsyn are found in the nervous 
system (Burns et al., 1997a), but acetylcholine clustering was still observed in the superior cervical ganglion of 
rapsyn – knockout mice (Feng et al., 1998b). It was found that the neurons of the superior cervical ganglion 
express a short isoform of rapsyn that does not support clustering of acetylcholine receptors and that clustering in 
these interneuronal synapses is not dependent on rapsyn. In vivo, clustering of neuronal acetylcholine receptors 
can be induced by full-length rapsyn, but these clusters do not reach the cell surface. For a more detailed review 
of the role of rapsyn and other ligands of dystroglycan in the neuromuscular junction see (Banks et al., 2003). 
 
Dystroglycan is essential for the clustering of acetylcholinesterase at the synaptic cleft (Peng et al., 1999; 
Arikawa-Hirasawa et al., 2002). It has been proposed that dystroglycan binds to perlecan, which in turn binds to 
acetylcholinesterase, building a ‘bridge’ between dystroglycan and the enzyme. Newer studies complicate that 
model, showing that MuSK is also involved in the formation of this complex (Cartaud et al., 2004). 
 
Function at Interneuronal Synapses 
So far, the presence of dystroglycan has been confirmed for postsynaptic terminals of cholinergic and 
GABAergic interneuronal synapses. Ionotropic receptors for acetylcholine and GABA share some characteristics 
and are distantly related to each.  
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The reported localization of dystroglycan in central synapses (Zaccaria et al., 2001a), retina and autonomic 
ganglia can be accounted for by the presence of cholinergic / GABAergic terminals. Gene knockout of one of the 
major binding partners of dystroglycan, dystrophin, affects the expression of acetylcholine receptors, GABA 
receptors and rapsyn in the brain, thus strengthening this connection (Wallis et al., 2004). However, a closer 
investigation would be necessary to exclude the presence of dystroglycan at other types of synapses.  
Dystroglycan and Cholinergic Synapses of the Superior Cervical Ganglion 
The group of Zaccaria et al. was one of the first to investigate the function of dystroglycan at interneuronal 
synapses, namely the cholinergic intraganglionic synapses of the superior cervical ganglion (SCG). The SCG is 
part of the sympathetic nervous system and is ideally suited for the study of the dystroglycan complex and 
synapse formation for several reasons. Most important are its parallels to the neuromuscular system: nicotinic 
acetylcholine receptors of the SCG are similar in sequence and biophysical properties to those at the NMJ, 
autonomic preganglionic neurons are related to motoneurons and cultured neurons of the SCG form functional 
synapses with myotubes in vitro (Kobayashi et al., 1984; Nurse and O'Lague, 1975). Most of the ligands of 
dystroglycan have been found to be present in the SCG, including agrin, dystrophin (Gingras and Ferns, 2001a), 
neurexin (Mochida, 1995), nitric oxide synthase (Dun et al., 1993) and rapsyn (Feng et al., 1998a). 
In the SCG, dystroglycan is localized to postsynaptic specializations together with acetylcholine receptors, 
dystrophin and spectrin.  
Transection of postganglionic axons (axotomy) leads to the detachment of presynaptic boutons and the 
disassembly of the synapses supplying the postganglionic neurons, which is followed by a reassembly when the 
severed axons regenerate. Zaccaria et al. observed a rapid decline of postsynaptic dystroglycan, dystrophin and 
acetylcholine receptors after axotomy, followed by a decrease of intraganglionic synapses. When the severed 
axons regenerated, the number of synapses and reactivity for dystroglycan and dystrophin increased, 
accompanied by a slower increase of acetylcholine receptors (Zaccaria et al., 1998b). On the mRNA level, 
acetylcholine receptor mRNA and dystrophin mRNA were decreased by postganglionic nerve crush, while 
dystroglycan mRNA were increased (Zaccaria et al., 2001b). 
The number of acetylcholine receptors and dystroglycan reactivity was found to be reduced in mdx mice that 
express a mutant dystrophin that cannot bind actin. Furthermore, the time-course of the decrease of 
intraganglionic synapses after axotomy was slowed in these mice, and the decrease of acetylcholine receptors, 
dystroglycan and dystrophin in relation to synapse number was totally abolished (Zaccaria et al., 2000). This 
suggests that the decrease seen in control wildtype mice is mediated by dystrophin and actin. 
The work of Zaccaria et al. highlights the role of dystroglycan in synaptic plasticity after neuronal injury and 
might also hint on an involvement of the dystroglycan complex in other forms of plasticity, i.e. those involved in 
learning and memory. It also poses an explanation for the autonomic imbalance observed in some cases of 
muscular dystrophy (Lanza et al., 2001; Yotsukura et al., 1995). 
 
Dystroglycan was found to be colocalized with agrin and other synaptic markers in synapses of the SCG in vitro 
as well as in vivo, together with acetylcholine receptors and PSD95 (Gingras and Ferns, 2001c). Dystroglycan / 
agrin staining was found in the form of small puncta on somata and proximal dendrites, which parallels the 
ultrastructural distribution in central neurons. SCG neurons expressed the membrane-bound isoform of agrin 
with the z insert (z+), while the secreted form was detected at a low level and could have also been produced by 
glial cells. Cultures of SCG neurons from agrin – deficient embryonic mice showed a reduction of synapse 
number and aberrant matching of pre- and postsynaptic terminals compared to control cultures (Gingras et al., 
2002). Synapse formation could be partially rescued by adding soluble z+ agrin to the culture medium, while z- 
agrin did not have an effect. Adding agrin antibodies to control cultures mimicked the effect of agrin deficiency. 
In vivo, agrin-deficiency impaired the matching of pre- and postsynaptic terminals, but the total number of 
synaptic terminals was not affected. Functional studies in vivo also revealed that paired pulse depression and 
post-tetanic potentiation were enhanced, which might hint to a defect of the presynaptic machinery. It has still to 
be confirmed whether the interaction between presynaptic agrin and postsynaptic dystroglycan is involved in the 
actions of agrin in the SCG or not. The different effects of z+ and z- agrin, both of which bind dystroglycan, 
weakens this hypothesis to some degree. 
Agrin in the CNS 
Disturbed agrin expression hampers synaptic differentiation in hippocampal neurons (Bose et al., 2000) and 
selectively attenuates the clustering of GABA receptors {Ferreira 1999 86 /id}. Agrin is also synthesized by 
retinal cells, is active in the clustering of acetylcholine receptors and colocalizes with synapses and gephyrin, a 
molecule involved in the clustering of certain GABA subunits (Koulen et al., 1999; Mann and Kroger, 1996).  
However, dystroglycan was clustered at GABAergic synapses in cultures of nerve cells with a total knockout of 
agrin (Levi et al., 2002b). This suggests that a loss of clustering of dystroglycan is not the reason for the effects 
observed in vivo, and that the interaction with other molecules (like neurexin) is responsible for the clustering of 
dystroglycan.  
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Agrin also participates in the formation of neuroeffector junctions of the autonomic nervous system, for instance, 
it is located to parasympathetic varicosities of the rat urinary bladder (Gingras et al., 2005). Application of agrin 
to rat adrenal slices led to a rapid switch in the phenotype of developing synapses between the splachnic nerve 
and the chromaffin cells, with the synapses shifting from electrical coupling to cholinergic transmission (Martin 
et al., 2005). 
It can be concluded that agrin is involved in the formation of central synapses and that it is localized to those 
types of synapses that also contain dystroglycan, but its exact function and its relation to dystroglycan remain 
unknown. The questions surrounding agrin in the central nervous system are further reviewed in (Smith and 
Hilgenberg, 2002a). 
The Neurexin Connection 
The α – and β – neurexins are key factors for the formation and function of presynaptic active zones. Clustering 
of presynaptic β – neurexin by postsynaptic neuroligin is sufficient to trigger the formation of the whole 
presynaptic apparatus (Dean et al., 2003b), and α – neurexin is implicated in the function of presynaptic calcium 
channels and vesicular exocytosis (Missler et al., 2003a). The only known binding partners for β – neurexins are 
neuroligin and dystroglycan. So far, the induction of presynaptic specialisations has only been demonstrated for 
neuroligin but not dystroglycan.  
Most research on the neuroligion / neurexin system is focused on its role in presynaptic differentiation in  
glutamatergic synapses, but more recent publications show that these molecules are also involved in the 
formation of GABAergic synapses (Levinson et al., 2005). It was also shown that the synaptogenic cue 
conferred by the binding of neuroligin to β - neurexin is not unidirectional: Not only does postsynaptic 
neuroligin induce presynaptic differentiation via neurexin binding; presynaptic neurexin can also induce 
postsynaptic differentiation via neuroligin binding in both glutamatergic and GABAergic synapses (Graf et al., 
2004). In the same experiments Graf et al. also demonstrated that dystroglycan was not clustered by neurexin 
like neuroligin was. 
Conversely to β – neurexins, the α – neurexins do not bind to neuroligin, which leaves dystroglycan as their only 
known postsynaptic binding partner. It seems that α – neurexins are of greater importance for GABAergic than 
for glutamatergic synapses. Total knockout of α – neurexins leads to a drastic reduction of GABAergic synapses 
in the brainstem and neocortex, while the number of glutamatergic synapses is unaffected (Missler et al., 2003b). 
This could hint on a functional similarity between neuroligin and dystroglycan in inhibitory synapses. Neuroligin 
and dystroglycan could be colocalized on postsynaptic terminals, giving rise to functional redundancy. 
The hypothesis of a presynaptic differentiation being triggered by dystroglycan via presynaptic neurexin is 
questioned by the work of Levi et al. (Levi et al., 2002c), who examined the time course of GABAergic synapse 
formation in vitro. They found that dystroglycan was clustered at synaptic loci after synaptic vesicles and the 
GABA receptors appeared at the nascent synapse. It is therefore unlikely that dystroglycan is essential for the 
major steps of presynaptic differentiation. 
It should be added that newer studies indicate that the action of neurexins on synaptic function is not confined to 
presynaptic terminals and describe postsynaptic effects (Kattenstroth et al., 2004).  
 
The presence of neurexin at neurons from the superior cervical ganglion has been demonstrated in vitro 
(Mochida, 1995), indicating that neurexin could also be of importance for cholinergic synapses. 
Dystroglycan at Central GABAergic Synapses 
Dystroglycan, dystrophin and syntrophin are clustered together with GABA(A) receptors in a subset of 
GABAergic synapses in the brain (Knuesel et al., 1999b; Levi et al., 2002d; Brunig et al., 2002b), and the 
number of GABA receptors at these synapses is reduced by about 50% in mdx mice that have a mutation in the 
dystrophin gene (Knuesel et al., 1999a). 
The decreased number of GABA receptors leads to alterations in synaptic plasticity. Short term depression, short 
term potentiation and the initial phase of long term potentiation (LTP) are facilitated in the CA1 region of 
hippocampal slices from mdx mice, and these effects are likely to be conferred by reduced GABAergic activity 
(Vaillend and Billard, 2002). 
A study that employed mice with a targeted deletion of dystroglycan in brain contrasts these findings. It found 
LTP upon high – frequency stimulation to be blunted at CA3 – CA1 synapses in hippocampal slices, while other 
parameters of neurotransmission were unchanged (Moore et al., 2002a). The study used a Cre/Lox system that 
affects a large proportion of glia and neurons in the brain (Zhuo et al., 2001), but it might be possible that the 
suppression of dystroglycan in the GABAergic cells was not sufficient. Furthermore, the knockout of 
dystroglycan led to a gross alteration of brain architecture, which makes it hard to compare functional findings 
between knockout and control group.  
The importance of dystroglycan in the formation of GABAergic synapses is questioned by in vitro cultures of 
neurons with a targeted deletion of dystroglycan. Lévi et al. showed that synapses of cultured neurons formed in 
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the absence of dystroglycan (Levi et al., 2002e). Furthermore, they showed that the clustering of dystroglycan at 
synapses could still be observed in the absence of agrin, gephyrin and dystrophin.  
Brunig et al. found that GABA receptors and gephyrin are sometimes mistargeted to glutamatergic synapses 
under certain culture conditions, but the dystroglycan associated complex was exclusively found opposed to 
GABAergic terminals (Brunig et al., 2002a). This means that a) clustering of GABA receptors is independent of 
the dystrophin associated complex, b) clustering of GABA receptors can be triggered both by glutamatergic and 
GABAergic terminals, c) dystroglycan can only be clustered by GABAergic, but not glutamatergic terminals, d) 
clustering of dystroglycan and GABA receptors is mediated by parallel mechanisms that are not interdependent. 
The mechanisms behind the clustering of GABA receptors remain unknown. 
Again, the findings suggest that the role of dystroglycan lies in the modulation and plasticity of synaptic function 
rather than in the direct initiation of synapse formation. 
GABA, Glutamate and Susceptibility for Seizures 
Through its function at inhibitory GABAergic synapses, it might be hypothesized that malfunction of 
dystroglycan and its associated proteins leads to phenomens of neuronal overexcitation, e.g. seizures and 
excitotoxic injury. The results so far are contradictory: Yoshihara et al. described reduced seizure susceptibility 
in mdx mice deficient in dystrophin (Yoshihara et al., 2003). They found reductions of the kainic acid receptor 
density in the brain and attributed the increased resistance towards seizures to this observation. They also found 
that the resistance to seizures induced by GABA – antagonists was not changed. Dystroglycan is not found at 
glutamatergic synapses, so the reduction of kainate receptors is likely to be cause by secondary mechanisms, i.e. 
in response to decreased inhibitory activity of GABAergic synapses or changes in brain development.  
The dystroglycan associated complex is also involved in the reaction to chemically induced seizures, as 
expression of dystrophin in neurons is altered in response to seizures, along with agrin and GABA(A) receptors 
(Knuesel et al., 2001d; O'Connor et al., 1995). 
Knuesel et al. found that knockout of utrophin, another protein associated with dystroglycan and located 
extrasynaptically, increased the vulnerability towards excitotoxicity and seizures induced by kainate (Knuesel et 
al., 2002c). They also observed that, upon excitotoxic injury, utrophin is expressed in neurons of the dentate 
gyrus that do not normally express this protein. They deduce that expression of utrophin is necessary for the 
structural stability and survival of neurons after injury, which points out to the fact that the influence of the 
dystroglycan complex on neuronal functioning is not solely confined to synaptic transmission. 
Myoclonus Dystonia 
Myoclonus dystonia is a hereditary movement disorder with symptoms of dystonia together with jerky 
movement and tremor, resembling myoclonus. Different genetic causes have been found for the disease, one 
being a mutation in the ε – sarcoglycan gene (Borges et al., 2000; Hjermind et al., 2003; Marechal et al., 2003; 
Doheny et al., 2002a). The transmembrane sarcoglycan complex is associated with dystroglycan in muscle and 
other tissues, and it has been hypothesised that sarcoglycans protect dystroglycan from degradation by matrix 
metalloproteinases (Yamada et al., 2001a). ε – sarcoglycan is the only member of the sarcoglycan family that 
was found to be expressed in central neurons. 
Myoclonus dystonia is associated with symptoms of anxiety, depression, obsessive – compulsive disorder and 
agoraphobia, epilepsy and cognitive deficits (Saunders-Pullman et al., 2002b; Doheny et al., 2002b; Foncke et 
al., 2003). The movement symptoms are responsive to ethanol and benzodiazepines, and comorbidity with 
alcohol addiction is reported (Saunders-Pullman et al., 2002a). In view of these findings, it seems very likely that 
the mutation of ε – sarcoglycan affects the stability of the dystroglycan complex at central GABAergic synapses, 
thereby leading to a reduction in synapse number and inhibitory transmission. 
The Link between Dysbindin and Schizophrenia 
Dysbindin is a binding partner of the dystroglycan complex and its mutation has recently been associated with 
schizophrenia. However, a later study found that, contrary to expectations, dysbindin expression is decreased in 
the presynaptic glutamatergic terminals in a subgroup of patients suffering from schizophrenia (Talbot et al., 
2004). The dystroglycan complex is absent from these nerve terminals, which suggests that dysbindin also has a 
function independent of the DGC and that the DGC is not involved in the symptoms observed. 
Myelinization and Glia 
Targeted deletion of dystroglycan in Schwann cells leads to impaired myelinization of axons and to a selective 
perturbation of the clustering of Na+ - channels at the nodes of Ranvier (Saito et al., 2003).  
The ion channels on a myelinated axon are distributed in correspondence with the periodic segments of 
myelinization (nodal, paranodal, juxtaparanodal, internodal). This distribution is upheld by the coordinated 
interaction between membrane proteins on the respective structures of the myelinating Schwann cell and their 
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binding partners on the membrane of the axon (reviewed in (Scherer and Arroyo, 2002)). The nodal segments of 
the axon are not tightly wrapped by the myelin sheath, but the Schwann cells extend microvilli that contact the 
surface of the nodal axon. These microvilli bear dystroglycan, which has proofed to be essential for the 
clustering of Na+ - channels in the nodal region. The deletion of dystroglycan in the study of Saito et al. resulted 
in malformation of the microvilli and a dispersal of the Na+ - channels along the axon, while the other ion 
channels were still confined to their axonal segments. This suggests that dystroglycan of the Schwann cell 
microvilli might interact with an unknown binding partner on the axonal surface that is able to bind to the Na+ - 
channels. It is intriguing to speculate that agrin, neurexin or a neurexin - related molecule might be that binding 
partner. Neurexin was detected on myelinated nerves innervating the Torpedo electric organ (Russell and 
Carlson, 1997). The proteins caspr and caspr2 are located to the axonal membrane and confer axonal 
specialisation at the paranodal and juxtaparanodal region, respectively. Both are structurally related to neurexins 
(in fact, caspr was termed ‘neurexin IV’ when it was first discovered, but proofed to be part of a distinct class of 
proteins afterwards).  
However, it is also possible that dystroglycan is solely responsible for the stabilisation of the microvilli, and that 
other proteins are involved in the interaction with the axonal surface.  
 
Dystroglycan also has important functions in astrocytes and for the functioning of the blood – brain barrier. In 
astrocytes, dystroglycan seems to be responsible for the aggregation of the potassium channel Kir4.1 and the 
aquaporin AQP4 in response to laminin (Guadagno and Moukhles, 2004c). Mdx mice with mutations of 
dystrophin also exhibit failures in the aggregation of AQP4 (Vajda et al., 2002), together with malformation and 
increased permeability of the blood – brain barrier (Nico et al., 2003). 
Outlooks 
In spite of its importance in various diseases the role of the dystroglycan complex in the nervous system remains 
enigmatic. This can be accounted for by its versatility: on one hand, defects involving the dystroglycan complex 
have a multitude of consequences which overshadow one another. On the other hand, dystroglycan seemingly 
transcends classical concepts of molecular biology by acting as both a mechanical building block and as a 
molecule in signal transduction. Lastly, the multitude of interactions with other cellular systems complicates the 
matter even more. It is likely that the molecular complex around dystroglycan serves a multitude of subtle 
synaptic functions instead of a single, clear – cut one. 
Dystroglycan and its associated molecules will certainly proof to be a worthwhile object of investigation in the 
next years and decades. Dystroglycan has so far only been characterized at central GABAergic and sympathetic 
cholinergic synapses, but not at other synapses and locations (e.g. central cholinergic synapses). Besides 
GABAergic and cholinergic synapses, other types of synapses might carry dystroglycan as well. Glycinergic 
synapses would be possible candidates, as they are phylogenetically related to nicotinic and muscarinic 
receptors. For the general investigation of the roles of dystroglycan in synaptic functioning, the superior cervical 
ganglion might proof as a useful model system, both in vivo and in vitro. Besides synaptic function, another short 
– term goal could be the investigation of myelinization in patients with muscular dystrophies. 
Long – term goals include the complete understanding of dystroglycan in brain development and synaptic 
plasticity. To achieve such an understanding, the mechanisms of this system must be investigated on different 
temporal and spatial scales and have to be integrated into a single theory. 
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